Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Intestine Bacterial Overgrowth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 0 results

Post-approval studies (Phase 4)Study completedNCT01769040
What this trial is testing

Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis

Who this might be right for
Liver CirrhosisAscites
Copenhagen University Hospital, Hvidovre 54
Testing effectiveness (Phase 2)UnknownNCT04501380
What this trial is testing

Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

Who this might be right for
Small Intestinal Bacterial OvergrowthGastrointestinal DiseaseGastrointestinal Infection
Bradley Connor 30
Not applicableUnknownNCT04867512
What this trial is testing

Botanical Blend on the Gut Microbiome and Gut-Skin-Axis in Small Intestinal Bacterial Overgrowth (SIBO)

Who this might be right for
Small Intestinal Bacterial Overgrowth (SIBO)
Integrative Skin Science and Research 35